Publication | Closed Access

Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide

InflammationCannabis UseHepatologyTlr4/mir-155/ Nfkb P65MedicineLiver PhysiologyImmunologyChronic InflammationHepatology InflammationHepatic FibrosisHepatotoxicityLiver DiseaseHepatology FibrosisPharmacologyCell SignalingCannabinoid Receptor 2Drug-induced Liver Injury